[ASAP] The Pharmacokinetics and Liver-Targeting Evaluation of Silybin Liposomes Mediated by the NTCP/OCTN2 Dual Receptors

AI Summary

This article discusses the pharmacokinetics and liver-targeting evaluation of silybin liposomes mediated by the NTCP/OCTN2 dual receptors. The study likely explores how targeting these receptors can enhance the delivery of silybin to the liver for more effective treatment. The findings could have implications for improving drug delivery strategies and treatment outcomes for liver-related diseases.